TURGUT ZIA: Open Payments
NPI 1699783894 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,706 in 122 payments from 28 companies in 2025. Trend: 2023 $2,471 · 2024 $2,177 · 2025 $2,706
Food & beverage: $2,666Education: $40
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $561 |
| Gilead Sciences, Inc. | 12 | $359 |
| Novo Nordisk Inc | 15 | $329 |
| Amgen Inc. | 8 | $142 |
| Lilly USA, LLC | 5 | $129 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| PFIZER INC. | 5 | $102 |
| E.R. Squibb & Sons, L.L.C. | 3 | $92 |
| Viatris Specialty LLC | 3 | $69 |
| Medtronic, Inc. | 1 | $67 |
Products named: ELIQUIS, DALVANCE, OTEZLA, VRAYLAR, LINZESS, FASENRA, JARDIANCE, YUPELRI.
Industry payments across WI — which companies pay providers there.
